Finegoldia magna (formerly Peptostreptococcus magnus): An overlooked etiology for toxic shock syndrome?

Medical Hypotheses

Volumn 79, Issue 2, 2012, Pages 138-140

  Rosenthal, Marnie E ^a   Rojtman, Albert D ^a   Frank, Elliot ^a  

^a JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFTRIAXONE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LINEZOLID; SUPERANTIGEN;

AGED; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL CHROMOSOME; BACTERIAL ENDOCARDITIS; BACTERIAL GENOME; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BONE INFECTION; CASE REPORT; FATALITY; FEMALE; FINEGOLDIA MAGNA; GENE SEQUENCE; GRAM POSITIVE BACTERIUM; HUMAN; HYPOTHESIS; INFECTIOUS ARTHRITIS; INTESTINE FLORA; MEDIASTINITIS; MOUTH FLORA; NONHUMAN; PATHOGENICITY; PEPTOSTREPTOCOCCUS; PEPTOSTREPTOCOCCUS MAGNUS; PLASMID; PROSTHESIS INFECTION; SKIN FLORA; SKIN INFECTION; TOXIC SHOCK SYNDROME;

AGED; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MODELS, BIOLOGICAL; PEPTOSTREPTOCOCCUS; SHOCK, SEPTIC;

FINEGOLDIA MAGNA; POSIBACTERIA;

EID: 84863326032     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.04.013     Document Type: Article

References (24)

1. Murdoch D.A., Shah H.N. Reclassification of Peptostreptococcus magnus (Prevot 1933) Holdeman and Moore 1972 as Finegoldia magna comb. nov. and Peptostreptococcus micros (Prevot 1933) Smith 1957 as Micromonas micros comb. nov. Anaerobe 1999, 5:555-559.
2. Tindall B.J., Euzeby J.P. Proposal of Parvimonas gen. nov. and Quatrionicoccus gen. nov. as replacements for the illegitimate, prokaryotic, generic names Micromonas Murdoch and Shah 2000 and Quadricoccus Maszenan et al. 2002, respectively. Int J Syst Evol Microbiol 2006, 56:2711-2713.
3. Murdoch D.A. Gram-positive anaerobic cocci. Clin Microbiol Rev 1998, 11:81-120.
4. Song Y., Liu C., McTeague M., Vu A., Liu J.Y., Finegold S.M. Rapid identification of Gram-positive anaerobic coccal species originally classified in the genus Peptostreptococcus by multiplex PCR assays using genus- and species-specific primers. Microbiology 2003, 149:1719-1727.
5. Veloo A.C., Erhard M., Welker M., Welling G.W., Degener J.E. Identification of Gram-positive anaerobic cocci by MALDI-TOF mass spectrometry. Syst Appl Microbiol 2011, 34:58-62.
6. Minces L.R., Shields R.K., Sheridan K., Ho K.S., Silveira F.P. Peptostreptococcus infective endocarditis and bacteremia. Analysis of cases at a tertiary medical center and review of the literature. Anaerobe 2010, 16:327-330.
7. Fournier P.E., La M.V., Casalta J.P., Richet H., Collart F., Raoult D. Finegoldia magna, an early post-operative cause of infectious endocarditis: report of two cases and review of the literature. Anaerobe 2008, 14:310-312.
8. Bassetti S., Laifer G., Goy G., Fluckiger U., Frei R. Endocarditis caused by Finegoldia magna (formerly Peptostreptococcus magnus): diagnosis depends on the blood culture system used. Diagn Microbiol Infect Dis 2003, 47:359-360.
9. van der Vorm E.R., Dondorp A.M., van Ketel R.J., Dankert J. Apparent culture-negative prosthetic valve endocarditis caused by Peptostreptococcus magnus. J Clin Microbiol 2000, 38:4640-4642.
10. Kerneis S., Matta M., Hoi A.B., et al. Postoperative mediastinitis due to Finegoldia magna with negative blood cultures. J Clin Microbiol 2009, 47:4180-4182.
11. Phelps R., Jacobs R.A. Purulent pericarditis and mediastinitis due to Peptococcus magnus. JAMA 1985, 254:947-948.
12. Panagou P., Papandreou L., Bouros D. Severe anaerobic necrotizing pneumonia complicated by pyopneumothorax and anaerobic monoarthritis due to Peptostreptococcus magnus. Respiration 1991, 58:223-225.
13. Sedano Gomez G.E., Perez de Llano L.A., Pita Carretero J. Necrotising pneumonia due to Finegoldia magna. Arch Bronconeumol 2011, 47:54-55.
14. Boyanova L., Vladimir D., Gergova G., et al. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study. Anaerobe 2004, 10:261-267.
15. Levy P.Y., Fenollar F., Stein A., Borrione F., Raoult D. Finegoldia magna: a forgotten pathogen in prosthetic joint infection rediscovered by molecular biology. Clin Infect Dis 2009, 49:1244-1247.
16. Krepel C.J., Gohr C.M., Walker A.P., Farmer S.G., Edmiston C.E. Enzymatically active Peptostreptococcus magnus: association with site of infection. J Clin Microbiol 1992, 30:2330-2334.
17. Karlsson C., Eliasson M., Olin A.I., et al. SufA of the opportunistic pathogen Finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation. J Biol Chem 2009, 284:29499-29508.
18. Akerstrom B., Bjorck L. Bacterial surface Protein L binds and inactivates neutrophil proteins S100A8/A9. J Immunol 2009, 183:4583-4592.
19. Genovese A., Borgia G., Bjorck L., et al. Immunoglobulin superantigen Protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE. J Immunol 2003, 170:1854-1861.
20. Goto T., Yamashita A., Hirakawa H., et al. Complete genome sequence of Finegoldia magna, an anaerobic opportunistic pathogen. DNA Res 2008, 15:39-47.
21. Frick I.M., Karlsson C., Morgelin M., et al. Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen. Mol Microbiol 2008, 70:695-708.
22. Behra-Miellet J., Calvet L., Dubreuil L. Activity of linezolid against anaerobic bacteria. Int J Antimicrob Agents 2003, 22:28-34.
23. Hawser S.P. Activity of tigecycline and comparators against recent clinical isolates of Finegoldia magna from Europe. Eur J Clin Microbiol Infect Dis 2010, 29:1011-1013.
24. Brazier J.S., Hall V., Morris T.E., Gal M., Duerden B.I. Antibiotic susceptibilities of Gram-positive anaerobic cocci: results of a sentinel study in England and Wales. J Antimicrob Chemother 2003, 52:224-228.